Labshake search
Citations for R&D Systems :
2051 - 2100 of 3392 citations for Testosterone D5 98% 100 Ug Ml In Dioxane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2021Quote: ... IL-15 and/or IL-21 (50 ng/ml; R&D Systems). Human B cells were cultured in FBS-RPMI at 37°C in 48-well plates for 24 ...
-
bioRxiv - Systems Biology 2020Quote: ... mouse anti-IL-10R blocking antibody (10 µg/mL, R&D Systems) or mouse anti-TNFα Receptors 1 and 2 (10 µg/mL ...
-
bioRxiv - Cancer Biology 2020Quote: ... with 20ng/ml IL-15 (R&D Systems, Bio-Techne, Lille, France). Cells were incubated or not with various drugs ...
-
bioRxiv - Biophysics 2021Quote: ... 1 μg/mL epidermal growth factor (EGF) (R&D Systems, #236-EG10), 10 μM ionomycin (Iono ...
-
bioRxiv - Biophysics 2020Quote: ... and 100ng/mL of recombinant interferon-γ (IFN-γ, R&D Systems) in RPMI-1640 media for 25min ...
-
bioRxiv - Biophysics 2020Quote: ... 10ng/mL recombinant tumor necrosis factor-α (TNF-α, R&D Systems), and 100ng/mL of recombinant interferon-γ (IFN-γ ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 30 ng/mL recombinant human EGF (R&D Systems, Minneapolis, MN). Cells were plated in a non-tissue culture treated 6-well plate and incubated overnight at 37°C ...
-
bioRxiv - Biochemistry 2022Quote: ... and 20 ng/ml of IL-13 (R&D Systems, #213-ILB). U937 cells were plated in complete RPMI 1640 for each condition ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 5ng/ml IL-2(# 202-IL-050/CF, R&D Systems). Activated CD3+ T cells were isolated from Dynabead Mouse T Activator CD3/CD28 (#00775477 ...
-
bioRxiv - Biochemistry 2022Quote: ... and 20 ng/mL fibroblast growth factor-3 (FGF3, R&D Systems) for the first 2 days and with 20 ng/mL FGF1 ...
-
bioRxiv - Immunology 2022Quote: ... IFN-γ is 9.4 – 600 pg/mL (R&D Systems, Minneapolis, USA) and IL-17 is 10.9 – 700 pg/mL (R&D Systems ...
-
bioRxiv - Immunology 2022Quote: ... the medium was supplemented with IL-12 (20ng/mL, R&D Systems). Differentiation of Treg cells was performed with TGF-β1 (2ng/mL).
-
bioRxiv - Cell Biology 2022Quote: ... human basic fibroblast growth factor (bFGF, 10 ng/ml, R&D Systems), and human fibroblast growth factor 10 (FGF10 ...
-
bioRxiv - Cancer Biology 2022Quote: ... 10 ng/mL fibroblast growth factor (R&D Systems #233-FB-025), 2% B27 (Thermo Fisher Scientific ...
-
bioRxiv - Bioengineering 2022Quote: ... or 1000 ng/mL of recombinant human IFN-γ (R&D Systems), TNF-α (R&D Systems) ...
-
bioRxiv - Bioengineering 2022Quote: ... and human fibroblast growth factor 2 (20 ng/mL, R&D Systems). hECSR was added to the bottom channel prior to addition of cells into the well ...
-
bioRxiv - Developmental Biology 2022Quote: ... and 10 ng/ml Activin A (R&D Systems #338-AC-010). After 48 h ...
-
bioRxiv - Cancer Biology 2022Quote: ... or 20ng/ml recombinant TGF-β (R&D Systems, 7666-MB-005) for 5-6 d before processing and analysis by described assays.
-
bioRxiv - Neuroscience 2020Quote: ... and 10 μL IL-34 stimulus (R&D systems, 5195-ML-CF) were incubated at 37°C for 30 minutes before 80 μL M-NFS-60 cells (103 cells/well ...
-
bioRxiv - Neuroscience 2021Quote: ... 2 mM L-glutamine and 20 ng/ml BDNF (R&D Systems). In each group (control and Celsr2 mutant) ...
-
bioRxiv - Molecular Biology 2020Quote: ... cells were stimulated with 50ng/ml BMP2 (R&D Systems, #355-GMP). Inhibition of the BMP signalling pathway was achieved through addition of LDN193187 dihydrochloride (Tocris ...
-
bioRxiv - Molecular Biology 2020Quote: ... siG9a cells were treated with 100ng/ml of rDKK1 (R&D Systems) or 200nM of porcupine inhibitor LGK974 (Selleck Chemicals ...
-
bioRxiv - Neuroscience 2020Quote: ... media was supplemented with 50 ng/ml FGF2 (R&D Systems, USA). On day seven ...
-
bioRxiv - Neuroscience 2022Quote: ... and supplemented with 20 ng/mL EGF (R&D Systems, 236-EG) and 20 ng/mL FGF2 (R&D Systems ...
-
bioRxiv - Cell Biology 2022Quote: ... 2) TGFβ2 (TGFβ2: 2.5 ng/ml; R&D Systems, Minneapolis, MN, USA) for 0-5 d followed by vehicle control (0.1% DMSO ...
-
bioRxiv - Pathology 2022Quote: ... MPT cells were treated with 20 ng/mL TNFα (R&D Systems) or 20 ng/mL IL-1β (R&D Systems ...
-
bioRxiv - Cancer Biology 2022Quote: ... 50 ng/mL EGF (R&D Systems, Minneapolis, MN, catalog #: 2028-EG), 100 ug/mL Noggin (PeproTech ...
-
bioRxiv - Genomics 2019Quote: ... and 40 ng/mL recombinant basic fibroblast growth factor (R&D Systems). Cells were differentiated into neurons for 7 days using standard differentiation medium ...
-
bioRxiv - Immunology 2020Quote: ... or a combination of 2 µg/ml ICAM-1 (R&D Systems), 1 µg/ml NKp30 (R&D systems ...
-
bioRxiv - Immunology 2019Quote: ... and 10 μg/ml of anti–IL-4 antibody (R&D Systems) were added at D0 ...
-
bioRxiv - Cell Biology 2019Quote: ... 1 mM glutamine supplemented with either Bmp4 (100ng/ml; R&D Systems) or FBS (10%).
-
bioRxiv - Developmental Biology 2019Quote: ... supplemented with 10 ng/mL stem cell factor (SCF; R&D Systems), 1 ng/mL IL3 ...
-
bioRxiv - Bioengineering 2020Quote: ... Collagen gel loaded with BMP-2 (75 μg/mL, R&D Systems) was used as a positive control ...
-
bioRxiv - Systems Biology 2021Quote: ... 200 ng/mL of recombinant human FGF5 (R&D Systems, #237-F5), 100 ng/mL of recombinant mouse PDGFA (Novus ...
-
bioRxiv - Bioengineering 2019Quote: ... IF procedures were performed for CD31 (R&D Systems; 10 µg/mL), osteopontin (goat polyclonal ...
-
bioRxiv - Immunology 2020Quote: ... 0.5 or 3 µg/mL (R&D Systems, Minneapolis, Minnesota, United States) in PBS buffer with 1.5% BSA and 0.025% Tween-20 ...
-
bioRxiv - Molecular Biology 2021Quote: ... 0.5 ng/mL recombinant mouse IL-2(R&D system, MN, USA), and 50 μM β-mercaptoethanol (Sigma Aldrich ...
-
bioRxiv - Molecular Biology 2021Quote: ... 0.5 ng/mL recombinant mouse IL-2 (R&D system, MN, USA), and 50 μM β-mercaptoethanol (Sigma Aldrich ...
-
bioRxiv - Physiology 2021Quote: ... and 30ng/mL recombinant mouse M-CSF (R&D systems, Minneapolis, MN). Fresh medium was replenished every 3 days ...
-
bioRxiv - Physiology 2021Quote: ... and 30ng/mL recombinant mouse M-CSF (R&D systems, Minneapolis, MN). Fresh medium was replenished every 3 days.
-
bioRxiv - Immunology 2020Quote: ... HUVEC were treated with 10ng/ml TNF-α (R&D Systems, UK) for 24 hours prior to experimentation.
-
bioRxiv - Immunology 2019Quote: ... and 10 μg/ml of anti–IL-4 antibody (R&D Systems) were added to RP10 media at day 0 ...
-
bioRxiv - Cancer Biology 2021Quote: ... and treated with 50 ng/ml of recombinant TRAIL (R&D Systems) for 4 hrs ...
-
bioRxiv - Immunology 2019Quote: ... carrier-free M-CSF (50 ng/ml, R&D Systems, Minneapolis, Minnesota) and GM-CSF (50 ng/ml ...
-
bioRxiv - Cancer Biology 2020Quote: ... or human IFNγ (50 ng/ml, #285-IF/CF, R&D Systems) was added to the medium ...
-
bioRxiv - Immunology 2019Quote: ... with or without 10ng/mL recombinant murine IL-23 (R&D Systems). To test the effect of VIP on ILC3 ...
-
bioRxiv - Developmental Biology 2021Quote: ... OPCs were treated with 50nG/mL IL1B (R&D Systems, Minneapolis, MN) or PBS for 4h ...
-
bioRxiv - Cell Biology 2021Quote: ... and the small molecules 25 ng/ml Activin A (R&D systems), 30 ng/ml Bone morphogenic protein-4 (BMP4 ...
-
bioRxiv - Systems Biology 2021Quote: ... Recombinant Mouse IGF-I/IGF-1 Protein (10ng/ml, R&D Systems), Transforming Growth Factor (TGF)β1 (10ng/ml ...
-
bioRxiv - Cancer Biology 2020Quote: ... 10 ng/mL NRG1-β1/HRG-β1 (396-HB, R&D Systems), 100 IU/mL penicillin/streptomycin and 1 μg/mL amphotericin B ...